| Name | N-Acetyl-L-α-aspartyl-L-asparaginyl-N-[(2S)-1-carboxy-3-oxo-2-propanyl]-L-leucinamide |
|---|---|
| Synonyms |
L-Leucinamide, N-acetyl-L-α-aspartyl-L-asparaginyl-N-[(1S)-2-carboxy-1-formylethyl]-
N-Acetyl-L-α-aspartyl-L-asparaginyl-N-[(2S)-1-carboxy-3-oxo-2-propanyl]-L-leucinamide |
| Description | Ac-DNLD-CHO (Ac-Asp-Asn-Leu-Asp-CHO) is a Caspase-3/7 inhibitor (IC50: 9.89, 245 nM respectively; Kiapp: 0.68, 55.7 nM respectively). Ac-DNLD-CHO can be used for research of caspase-mediated apoptosis diseases, such as neurodegenerative disorders and viral infection diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
Caspase-3/7[1] |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 1034.0±65.0 °C at 760 mmHg |
| Molecular Formula | C20H31N5O10 |
| Molecular Weight | 501.488 |
| Flash Point | 579.1±34.3 °C |
| Exact Mass | 501.207092 |
| LogP | -0.50 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.536 |